-10.44% percent quarterly performance for Lexicon Pharmaceuticals Inc (LXRX) is not indicative of the underlying story
On Monday, Lexicon Pharmaceuticals Inc (NASDAQ: LXRX) was -4.12% drop from the session beforebefore settling in for the closing price of $1.70. A 52-week range